MENU
CADL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Candel Therapeutics (CADL) Ownership - Who owns Candel Therapeutics?
Profile
Industry
N/A
Address
117 Kendrick Street
Phone
+1 617 916-5445
Employees
42
Web
https://www.candeltx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
280.34M
P/E Ratio
N/A
Total Cash
16.56M
Projected Growth
N/A
Total Debt
16.02M
Revenue
N/A
Risk (Beta)
-0.81
Dividend Yield
N/A
Total Cash/Share
0.39
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CADL
Capitalization
280M
P/E Ratio
N/A
Risk (Beta)
-0.81
Dividend Yield
N/A
Total Cash
16.6M
Total Cash/Share
0.39
Total Debt
16M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-15.26M
P/B Ratio
27.78
Cash Flow
N/A
Earnings
-1.73
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
322K
Current Ratio
1.18
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-48.83M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-145.85
Shares Held By Institutions
60M
Shares Outstanding - Current
42.5M
Total Liabilities
36.8M
Total Volume MTD
N/A
Value
-1
Gain YTD
348.980
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
117 Kendrick Street
Phone
+1 617 916-5445
Employees
42
Web
https://www.candeltx.com